WINTON GROUP Ltd lessened its holdings in Chemours Co (NYSE:CC) by 23.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 46,103 shares of the specialty chemicals company’s stock after selling 13,902 shares during the quarter. WINTON GROUP Ltd’s holdings in Chemours were worth $2,308,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of CC. Nationwide Fund Advisors increased its holdings in Chemours by 10.3% in the third quarter. Nationwide Fund Advisors now owns 545,708 shares of the specialty chemicals company’s stock valued at $27,618,000 after buying an additional 51,098 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its holdings in Chemours by 46.6% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 21,162 shares of the specialty chemicals company’s stock valued at $1,071,000 after buying an additional 6,722 shares during the last quarter. Crossmark Global Holdings Inc. acquired a new position in Chemours in the third quarter valued at $942,000. Gamco Investors INC. ET AL acquired a new position in Chemours in the third quarter valued at $202,000. Finally, Smith Asset Management Group LP boosted its stake in Chemours by 3.1% in the third quarter. Smith Asset Management Group LP now owns 44,489 shares of the specialty chemicals company’s stock valued at $2,252,000 after acquiring an additional 1,333 shares in the last quarter. 76.92% of the stock is currently owned by hedge funds and other institutional investors.
In other news, insider Christian W. Siemer sold 15,088 shares of the stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $47.37, for a total transaction of $714,718.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Paul Kirsch sold 13,770 shares of the stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $50.01, for a total transaction of $688,637.70. Following the sale, the insider now owns 63,093 shares of the company’s stock, valued at approximately $3,155,280.93. The disclosure for this sale can be found here. Insiders have sold 58,239 shares of company stock valued at $2,848,608 in the last quarter. Insiders own 1.14% of the company’s stock.
Shares of Chemours Co (CC) opened at $50.06 on Friday. Chemours Co has a 12 month low of $32.31 and a 12 month high of $58.08. The firm has a market cap of $9,410.00 and a PE ratio of 9.57. The company has a current ratio of 2.12, a quick ratio of 1.55 and a debt-to-equity ratio of 4.74.
Chemours (NYSE:CC) last announced its earnings results on Wednesday, February 14th. The specialty chemicals company reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.24. Chemours had a net margin of 12.06% and a return on equity of 115.54%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter in the prior year, the firm earned $0.08 earnings per share. The business’s quarterly revenue was up 19.1% compared to the same quarter last year. research analysts expect that Chemours Co will post 5.3 EPS for the current fiscal year.
Chemours announced that its Board of Directors has authorized a stock repurchase program on Friday, December 1st that allows the company to buyback $500.00 million in shares. This buyback authorization allows the specialty chemicals company to buy shares of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.
TRADEMARK VIOLATION WARNING: This report was originally reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.tickerreport.com/banking-finance/3253326/chemours-co-cc-position-reduced-by-winton-group-ltd.html.
The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.
Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemours Co (NYSE:CC).
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.